AstraZeneca Pharmaceutical
Asia, Shanghai, China, Shanghai'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
Description
AstraZeneca Pharmaceutical operAstraZeneca is a science-led biopharmaceutical and medicines used by millions of patients.
Investor Profile
AstraZeneca Pharmaceutical has made 2 investments, with 1 in the past 12 months and 50% as lead.
Stage Focus
- Series B (50%)
- Series A (50%)
Country Focus
- China (100%)
Industry Focus
- Manufacturing
- Medical Device
- Artificial Intelligence (Ai)
- Biotechnology
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
'/%3e%3cuse xlink:href='%23a' transform='translate(288.889 -214.211)'/%3e%3cuse xlink:href='%23a' transform='translate(108 342.749)'/%3e%3cuse xlink:href='%23a' transform='translate(469.189 342.749)'/%3e%3c/svg%3e)
